Differences in biopsychosocial profiles of diabetes patients by level of glycaemic control and health-related quality of life: The Maastricht Study

scientific article

Differences in biopsychosocial profiles of diabetes patients by level of glycaemic control and health-related quality of life: The Maastricht Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0182053
P932PMC publication ID5531491
P698PubMed publication ID28750026

P50authorMiranda SchramQ55061691
Tos BerendschotQ56587595
Annemarie KosterQ67421856
Hans BosmaQ68595915
Coenraad Dirk Adriaan StehouwerQ68596151
Dirk RuwaardQ80863991
Nicolaas SchaperQ82748432
Arianne M. J. ElissenQ89766585
P2093author name stringPieter C Dagnelie
Carla J van der Kallen
Ronald M Henry
Dorijn F L Hertroijs
Johannes S A G Schouten
P2860cites workManagement of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Q22241288
Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomesQ33652884
Societal and individual determinants of medical care utilization in the United StatesQ34204043
The structure of copingQ34262262
Health-related quality of life in diabetic people with different vascular riskQ34418579
Emerging trends in optical sensing of glycemic markers for diabetes monitoringQ34971110
Utility of different glycemic control metrics for optimizing management of diabetesQ35049855
Profiling Patients' Healthcare Needs to Support Integrated, Person-Centered Models for Long-Term Disease Management (Profile): Research Design.Q37241197
Overcoming fragmentation in health care: chronic care in Austria, Germany and The NetherlandsQ37973530
Dutch diabetes prevalence estimates (DUDE-1).Q38929045
Good friends, high income or resilience? What matters most for elderly patients?Q39289668
Do psychosocial profiles predict self-rated health, morbidity and mortality in late middle-aged and older people?Q39471846
Estimated GFR, Albuminuria, and Cognitive Performance: The Maastricht StudyQ40705818
Lower verbal intelligence is associated with diabetic complications and slower walking speed in people with Type 2 diabetes: the Maastricht StudyQ40880618
Can metabolic control variables of diabetic patients predict their quality of life?Q40926469
A guide to constructs of controlQ41130958
Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trialsQ42326639
Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulinQ43797077
Toward tailored disease management for type 2 diabetes.Q45323852
Association between glycaemic control and quality of life in diabetes mellitus.Q45931347
The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities.Q48308564
Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trialQ48785114
Meta-analysis of the effectiveness of chronic care management for diabetes: investigating heterogeneity in outcomes.Q50767251
Material vs. psychosocial explanations of old-age educational differences in physical and mental functioning.Q50799559
Monitoring depression treatment outcomes with the patient health questionnaire-9.Q51935578
Early results from adoption of bundled payment for diabetes care in the Netherlands show improvement in care coordination.Q54507978
The Biopsychosocial Revolution: Interviewing and Provider-patient Relationships Becoming Key Issues for Primary Care.Q55514537
The Self-Efficacy Scale: Construction and ValidationQ56431506
[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]Q60629825
Integrating care through bundled payments--lessons from The NetherlandsQ83629967
Standardizing Patient Outcomes MeasurementQ87263505
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectquality of lifeQ13100823
The Maastricht StudyQ123734155
P304page(s)e0182053
P577publication date2017-07-27
P1433published inPLOS OneQ564954
P1476titleDifferences in biopsychosocial profiles of diabetes patients by level of glycaemic control and health-related quality of life: The Maastricht Study
P478volume12

Reverse relations

cites work (P2860)
Q89950406Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study
Q91670610Factors that influence the intended intensity of diabetes care in a person-centred setting
Q47594234Functional status mediates the association between peripheral neuropathy and health-related quality of life in individuals with diabetes
Q94541296Quality performance and associated factors in Swiss diabetes care - A cross-sectional study
Q92665282Relevant patient characteristics for estimating healthcare needs according to healthcare providers and people with type 2 diabetes: a Delphi survey
Q48511739Relevant patient characteristics for guiding tailored integrated diabetes primary care: a systematic review.
Q55044866Socioeconomic inequalities in cardiometabolic control in patients with type 2 diabetes.
Q92816495The Impact of Cytokines on the Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus

Search more.